$24.730
-0.267 (-1.08%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PTHS Prediction & Forecast by Similar Chart Analysis
Alphio's PTHS stock price prediction model matches the current Pelthos Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $24.86 (+0.54%). The 1-week path is $26.47 (+7.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Pelthos Therapeutics Inc Stock?
Pelthos Therapeutics Inc is not a good buy right now due to its current price of $24.73, which is significantly below the lowest analyst price target of $45, indicating a potential downside. Additionally, the RSI of 31.416 suggests that the stock is oversold, but the negative earnings report with an EPS of -6.62 raises concerns about its financial health. The main risk is the company's high net loss of $23.4 million in Q2 2026, which could impact future growth prospects.
PTHS stock price ended at $24.73 on Friday, after losing -1.08%
Pelthos Therapeutics Inc (PTHS) last closed at $24.73, losing -1.08%. These facts feed the 1-day and 1-week PTHS price prediction above.
Forecast Drivers
Pelthos Therapeutics Inc (PTHS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PTHS, ranked by similarity.
Seasonality analysis for PTHS
Historically the probability of a positive August return for PTHS is 0.00%. June offers the highest probability of a positive month at 4.76%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PTHS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $16.64 | $18.12 | $18.29 | -26.74% |
| Sep 2026 | $15.33 | $18.12 | $20.44 | -26.74% |
| Oct 2026 | $20.11 | $20.65 | $22.23 | -16.50% |
| Nov 2026 | $18.26 | $20.09 | $20.47 | -18.75% |
| Dec 2026 | $23.29 | $23.56 | $26.27 | -4.71% |
In 2026, Pelthos Therapeutics Inc (PTHS) is projected to range from $15.33 to $26.27.
Pelthos Therapeutics Inc 2026 monthly forecast
In Aug 2026, Pelthos Therapeutics Inc is projected to average $18.12, with a low of $16.64 and high of $18.29.
In Sep 2026, Pelthos Therapeutics Inc is projected to average $18.12, with a low of $15.33 and high of $20.44.
In Oct 2026, Pelthos Therapeutics Inc is projected to average $20.65, with a low of $20.11 and high of $22.23.
In Nov 2026, Pelthos Therapeutics Inc is projected to average $20.09, with a low of $18.26 and high of $20.47.
In Dec 2026, Pelthos Therapeutics Inc is projected to average $23.56, with a low of $23.29 and high of $26.27.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.